Membrane rafts in endothelial cells and their modulation by proatherogenic stimuli

Drug Discovery Today: Disease Mechanisms

Volumn 4, Issue 1, 2007, Pages 11-19

  Patschan, Susann ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; RECEPTOR;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; LIPID RAFT; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SHEAR FLOW; SHEAR STRESS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 47049129634     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2007.06.001     Document Type: Review

References (59)

1. Vane J.R., et al. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323 (1990) 27-36
2. Mineo C., and Shaul P.W. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc. Res. 70 (2006) 31-41
3. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
4. Holthuis J.C., and Levine T.P. Lipid traffic: floppy drives and a superhighway. Nat. Rev. Mol. Cell Biol. 6 (2005) 209-220
5. Anderson R.G., and Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296 (2002) 1821-1825
6. Maxfield F.R. Plasma membrane microdomains. Curr. Opin. Cell Biol. 14 (2002) 483-487
7. Pike L.J. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J. Lipid. Res. 47 (2006) 1597-1598
8. Gratton J.P., et al. Caveolae and caveolins in the cardiovascular system. Circ. Res. 94 (2004) 1408-1417
9. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
10. Frank P.G., et al. Caveolin, caveolae, and endothelial cell function. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1161-1168
11. Liu J., et al. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J. Biol. Chem. 272 (1997) 7211-7222
12. Sprenger R.R., et al. Spatial segregation of transport and signalling functions between human endothelial caveolae and lipid raft proteomes. Biochem. J. 400 (2006) 401-410
13. Oh P., and Schnitzer J.E. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 12 (2001) 685-698
14. Munro S. Lipid rafts: elusive or illusive?. Cell 115 (2003) 377-388
15. Futerman A.H., and Hannun Y.A. The complex life of simple sphingolipids. EMBO Rep. 5 (2004) 777-782
16. Hancock J.F. Lipid rafts: contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol. 7 (2006) 456-462
17. De Angelis D.A., et al. PRIM: proximity imaging of green fluorescent protein-tagged polypeptides. Proc. Natl. Acad. Sci. U S A 95 (1998) 12312-12316
18. Sharma P., et al. Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell 116 (2004) 577-589
19. Patschan S., et al. Probing lipid rafts with proximity imaging: actions of proatherogenic stimuli. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2210-H2219
20. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1 (2000) 31-39
21. Shaul P.W. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J. Physiol. 547 Pt 1 (2003) 21-33
22. Shaul P.W. Regulation of endothelial nitric oxide synthase: location, location, location. Annu. Rev. Physiol. 64 (2002) 749-774
23. Bucci M., et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 6 (2000) 1362-1367
24. Sowa G., et al. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc. Natl. Acad. Sci. U S A 98 (2001) 14072-14077
25. Goligorsky M.S., et al. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am. J. Physiol. Renal Physiol. 283 (2002) F1-F10
26. Li H., et al. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold. Circ. Res. 88 (2001) 229-236
27. Zhang A.Y., et al. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 47 (2006) 74-80
28. 2 prosurvival effects in cultured endothelial cells. FASEB J. 20 (2006) 1501-1503
29. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8 (2002) 1211-1217
30. Uittenbogaard A., and Smart E.J. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae. J. Biol. Chem. 275 (2000) 25595-25599
31. Uittenbogaard A., et al. Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex. J. Biol. Chem. 277 (2002) 4925-4931
32. Uittenbogaard A., et al. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J. Biol. Chem. 275 (2000) 11278-11283
33. Flavahan N.A. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 85 (1992) 1927-1938
34. Cohen A.W., et al. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84 (2004) 1341-1379
35. Blair A., et al. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J. Biol. Chem. 274 (1999) 32512-32519
36. Zeng Y., et al. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J. Biol. Chem. 278 (2003) 45931-45936
37. Byfield F.J., et al. OxLDL increases endothelial stiffness, force generation, and network formation. J. Lipid Res. 47 (2006) 715-723
38. Rizzo V., et al. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J. Biol. Chem. 273 (1998) 34724-34729
39. Boyd N.L., et al. Chronic shear induces caveolae formation and alters ERK and Akt responses in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H1113-H1122
40. Sun R.J., et al. Shear stress induces caveolin-1 translocation in cultured endothelial cells. Eur. Biophys J. 30 (2002) 605-611
41. Sun R.J., et al. Caveolin-1 redistribution in human endothelial cells induced by laminar flow and cytokine. Biorheology 40 (2003) 31-39
42. Park H., et al. Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J. Biol. Chem. 273 (1998) 32304-32311
43. Yu J., et al. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J. Clin. Invest. 116 (2006) 1284-1291
44. Huang H., et al. Cell mechanics and mechanotransduction: pathways, probes, and physiology. Am. J. Physiol. Cell Physiol. 287 (2004) C1-C11
45. Wary K.K., et al. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94 (1998) 625-634
46. Sedding D.G., et al. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ. Res. 96 (2005) 635-642
47. Shay-Salit A., et al. VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc. Natl. Acad. Sci. U S A 99 (2002) 9462-9467
48. Stitt A.W., et al. Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains. FASEB J. 14 (2000) 2390-2392
49. Wautier M.P., et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E685-E694
50. Lander H.M., et al. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 272 (1997) 17810-17814
51. Basta G., et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105 (2002) 816-822
52. Kiely J.M., et al. Lipid raft localization of cell surface E-selectin is required for ligation-induced activation of phospholipase C gamma. J. Immunol. 171 (2003) 3216-3224
53. Yamabhai M., and Anderson R.G. Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts. J. Biol. Chem. 277 (2002) 24843-24846
54. Ning Y., Buranda T., and Hudson L.G. Activated epidermal growth factor receptor induces integrin alpha2 internalization via caveolae/raft-dependent endocytic pathway. J. Biol. Chem. 282 9 (2007) 6380-6387
55. Walton K.A., et al. A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J. Lipid Res. 47 (2006) 1967-1974
56. Ikeda S., et al. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 96 (2005) 467-475
57. Bae J.S., et al. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc. Natl. Acad. Sci. U S A (2007)
58. Kobayashi H., et al. Induction of aquaporin 1 by dexamethasone in lipid rafts in immortalized brain microvascular endothelial cells. Brain Res. 1123 (2006) 12-19
59. Blasi F., and Carmeliet P. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3 12 (2002) 932-943 Review